It reduces TNF-alpha production along with IL-1beta, IL-6, IL-8, and other cytokines at the transcriptional level
Certain groups should exercise particular caution or avoid BPC-157 entirely: individuals with active cancer or significant cancer history, pregnant or breastfeeding women (no safety data exists), those taking blood thinners (potential interaction effects), and anyone with autoimmune conditions affecting connective tissue
Studies commonly focus on tendon and ligament injury models, muscle damage, wound healing, and gut irritation or ulcer models
If you require any cosmetic ingredients, call or contact us
BPC 157 is growing in popularity for the treatment of a variety of conditions